Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Enterprise Value (2020 - 2026)

Cellebrite DI's Enterprise Value history spans 6 years, with the latest figure at -$285.5 million for Q4 2025.

  • Quarterly Enterprise Value rose 17.34% to -$285.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$285.5 million through Dec 2025, up 17.34% year-over-year, with the annual reading at -$285.5 million for FY2025, 17.34% up from the prior year.
  • Enterprise Value came in at -$285.5 million for Q4 2025, down from -$281.4 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$90.5 million in Q1 2025 to a low of -$345.4 million in Q4 2024.
  • The 5-year median for Enterprise Value is -$139.4 million (2021), against an average of -$162.5 million.
  • Year-over-year, Enterprise Value surged 33.25% in 2022 and then crashed 106.35% in 2025.
  • Cellebrite DI's Enterprise Value stood at -$133.8 million in 2021, then increased by 1.16% to -$132.3 million in 2022, then tumbled by 72.51% to -$228.2 million in 2023, then plummeted by 51.35% to -$345.4 million in 2024, then rose by 17.34% to -$285.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Enterprise Value are -$285.5 million (Q4 2025), -$281.4 million (Q3 2025), and -$179.2 million (Q2 2025).